1-3 of 3
Rose C. Beck
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Brentuximab Vedotin, Nivolumab, Doxorubicin, and Dacarbazine (AN+AD) for Early-Stage Classical Hodgkin Lymphoma (SGN35-027 Part C)

Jeremy S. Abramson, David J. Straus, Nancy L. Bartlett, John M. Burke, Ryan C Lynch, Eva Domingo Domenech, Brian Hess, Steven R. Schuster, Yuliya Linhares, Rod Ramchandren, Mitul Gandhi, Rex Mowat, Harsh Shah, Wojciech Jurczak, Alessandro Re, Uwe Hahn, H. Miles Prince, Wenchuan Guo, Linda Ho, Rose C. Beck, Christopher A. Yasenchak, Hun Ju Lee
Journal: Blood
Blood (2023) 142 (Supplement 1): 611.
https://doi.org/10.1182/blood-2023-172574
Published: 2023
Journal Articles

MUM1 Expression in Follicular Lymphoma Identifies a Group of Patients with Poor Overall Survival.

Rose C. Beck, MD, PhD, Ahmed Absi, MD, Tony Jin, MS, Brad Pohlman, MD, Eric D. His, MD
Journal: Blood
Blood (2005) 106 (11): 990.
https://doi.org/10.1182/blood.V106.11.990.990
Published: 2005
Journal Articles

Efficient Identification of T-Cell Clones Associated with Graft-Versus-Host Disease (GvHD) in Target Tissue for Subsequent Detection in Peripheral Blood.

Rose C. Beck, MD, PhD, Marcin Wlodarski, Karl S. Theil, MD, Ralph Tuthill, MD, Brian Bolwell, MD, Ronald Sobecks, MD, Jaroslaw P. Maciejewski, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 2243.
https://doi.org/10.1182/blood.V104.11.2243.2243
Published: 2004